In contrast, Ho et al. (2013) reported tumor suppressive effects of MSCs via modification of Akt signaling, shown by the coadministration of MSCs and glioma cells resulting in a significant reduction in tumor volume and vascular density. The gene discussed is AKT1; the disease is neoplasm.